Identify KIPS (Kinase Privileged Scaffolds) and use Multicomponent rapid chemical synthesis reactions to generate novel highly effective kinase inhibitors.

Highly versatile system. Straightforward synthesis, custom medicinal Chemistry to achieve drug-like properties and rational design of chemical matter to achieve desired selectivity

Optimize target specificity of compounds based both on the clinical landscape of evolving mutations in the primary target and ‘collaborating’ kinases that confer resistance.

Using our scientific expertise and proprietary technology we have generated a library of compounds that includes many best-in-class drug candidates. Our discovery engine constantly expands and refines this library.